Get access

Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus

Authors

  • Abigail I. Wald BS,

    1. Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
    Search for more papers by this author
  • Elizabeth E. Hoskins MS,

    1. Division of Hematology/Oncology, Cincinnati's Children's Hospital Medical Center, Cincinnati, Ohio
    Search for more papers by this author
  • Susanne I. Wells PhD,

    1. Division of Hematology/Oncology, Cincinnati's Children's Hospital Medical Center, Cincinnati, Ohio
    Search for more papers by this author
  • Robert L. Ferris MD, PhD,

    1. Departments of Otolaryngology and Immunology, University of Pittsburgh Medical Center and Cancer Institute, Pittsburgh, Pennsylvania
    Search for more papers by this author
  • Saleem A. Khan PhD

    Corresponding author
    1. Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
    • Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
    Search for more papers by this author

Abstract

Background

Human papillomavirus (HPV)-positive cases of squamous cell carcinoma of the head and neck (SCCHN) have a much better disease outcome compared to SCCHN cases lacking HPV. Differences in microRNA (miRNA) expression may affect their clinical outcomes.

Methods

The miRNA expression was studied using microarrays and quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) in HPV-16-positive and HPV-negative SCCHN cell lines. The role of HPV-16 E6 and E7 oncogenes in altering miRNA expression was investigated using human foreskin keratinocytes (HFKs).

Results

The miRNAs miR-363, miR-33, and miR-497 were upregulated, whereas miR-155, miR-181a, miR-181b, miR-29a, miR-218, miR-222, miR-221, and miR-142-5p were downregulated in HPV-positive cells compared to both HPV-negative SCCHN and normal oral keratinocytes. HPV-16 E6 oncogene altered miRNA expression in HFKs and in an HPV-16–positive cell line with E6 knockdown using siRNA.

Conclusion

miRNAs differentially expressed in the presence of HPV-16 may provide biomarkers for SCCHN and identify cellular pathways targeted by this virus. © 2010 Wiley Periodicals, Inc. Head Neck, 2011

Get access to the full text of this article

Ancillary